The human immunodeficiency virus type 1 Vpr protein upregulates PVR via activation of the ATR-mediated DNA damage response pathway

Journal of General Virology

Volumn 94, Issue PART 12, 2013, Pages 2664-2669

  Vassena, Lia ^a   Giuliani, Erica ^a   Matusali, Giulia ^a,c   Cohen, Éric A ^b   Doria, Margherita ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATR PROTEIN; HISTONE H2AX; INTERLEUKIN 2; NEF PROTEIN; PROTEIN PVR; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VIRUS PROTEIN; VPR PROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL CYCLE G2 PHASE; CYTOTOXIC LYMPHOCYTE; DNA DAMAGE; DNA INTEGRATION; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; INTERNAL RIBOSOME ENTRY SITE; MOLECULAR INTERACTION; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION;

ATAXIA TELANGIECTASIA MUTATED PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; DNA DAMAGE; G2 PHASE; HIV INFECTIONS; HIV-1; HUMANS; JURKAT CELLS; RECEPTORS, VIRUS; UP-REGULATION; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84887508280     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.055541-0     Document Type: Article

References (18)

1. Andersen, J. L., Le Rouzic, E. & Planelles, V. (2008). HIV-1 Vpr: mechanisms of G2 arrest and apoptosis. Exp Mol Pathol 85, 2-10.
2. Ardolino, M., Zingoni, A., Cerboni, C., Cecere, F., Soriani, A., Iannitto, M. L. & Santoni, A. (2011). DNAM-1 ligand expression on Agstimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction. Blood 117, 4778-4786.
3. Belzile, J. P., Duisit, G., Rougeau, N., Mercier, J., Finzi, A. & Cohen, E. A. (2007). HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase. PLoS Pathog 3, e85.
4. Cerboni, C., Zingoni, A., Cippitelli, M., Piccoli, M., Frati, L. & Santoni, A. (2007a). Antigen-activated human T lymphocytes express cellsurface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis. Blood 110, 606-615.
5. Cerboni, C., Neri, F., Casartelli, N., Zingoni, A., Cosman, D., Rossi, P., Santoni, A. & Doria, M. (2007b). Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J Gen Virol 88, 242-250.
6. Eissmann, P., Evans, J. H., Mehrabi, M., Rose, E. L., Nedvetzki, S. & Davis, D. M. (2010). Multiple mechanisms downstream of TLR-4 stimulation allow expression of NKG2D ligands to facilitate macrophage/NK cell crosstalk. J Immunol 184, 6901-6909.
7. Gasser, S., Orsulic, S., Brown, E. J. & Raulet, D. H. (2005). The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436, 1186-1190.
8. Goh, W. C., Rogel, M. E., Kinsey, C. M., Michael, S. F., Fultz, P. N., Nowak, M. A., Hahn, B. H. & Emerman, M. (1998). HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat Med 4, 65-71.
9. Kirchhoff, F. (2010). Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 8, 55-67.
10. Lau, A., Swinbank, K. M., Ahmed, P. S., Taylor, D. L., Jackson, S. P., Smith, G. C. & O'Connor, M. J. (2005). Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase. Nat Cell Biol 7, 493-500.
11. Mansky, L. M., Preveral, S., Selig, L., Benarous, R. & Benichou, S. (2000). The interaction of Vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 in vivo mutation rate. J Virol 74, 7039-7047.
12. Matusali, G., Potestà, M., Santoni, A., Cerboni, C. & Doria, M. (2012). The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR. J Virol 86, 4496-4504.
13. Norman, J. M., Mashiba, M., McNamara, L. A., Onafuwa-Nuga, A., Chiari-Fort, E., Shen, W. & Collins, K. L. (2011). The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells. Nat Immunol 12, 975-983.
14. Richard, J., Sindhu, S., Pham, T. N., Belzile, J. P. & Cohen, E. A. (2010). HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing. Blood 115, 1354-1363.
15. Soriani, A., Zingoni, A., Cerboni, C., Iannitto, M. L., Ricciardi, M. R., Di Gialleonardo, V., Cippitelli, M., Fionda, C., Petrucci, M. T. & other authors (2009). ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood 113, 3503-3511.
16. Stern-Ginossar, N., Gur, C., Biton, M., Horwitz, E., Elboim, M., Stanietsky, N., Mandelboim, M. & Mandelboim, O. (2008). Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat Immunol 9, 1065-1073.
17. Takai, Y., Miyoshi, J., Ikeda, W. & Ogita, H. (2008). Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation. Nat Rev Mol Cell Biol 9, 603-615.
18. Ward, J., Davis, Z., DeHart, J., Zimmerman, E., Bosque, A., Brunetta, E., Mavilio, D., Planelles, V. & Barker, E. (2009). HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response. PLoS Pathog 5, e1000613.